{"entity":{"type":"insider","cik":"0001861684","url":"/insider/0001861684","json_url":"/insider/0001861684.json","name":"Young Joseph R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2023-02-08","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"Young Joseph R","source":"filing","n_filings":6,"first_seen":"2023-02-08","last_seen":"2026-02-25"}],"transactions":[{"id":5938281,"accession":"0001861684-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001861684-26-000004","line_url":"/filing/0001861684-26-000004#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3117.0,"shares_display":"3,117","price_per_share":41.9839,"price_display":"41.98","price_state":"stated","total_value":130863.8163,"total_display":"130,863.82","total_whole":"130,864","shares_owned_after":64722.0,"shares_owned_after_display":"64,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5108204,"accession":"0001193125-25-280792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-280792","line_url":"/filing/0001193125-25-280792#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":29.0583,"price_display":"29.06","price_state":"stated","total_value":435874.5,"total_display":"435,874.50","total_whole":"435,875","shares_owned_after":47839.0,"shares_owned_after_display":"47,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider"},{"id":2278540,"accession":"0001415889-24-013504","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-013504","line_url":"/filing/0001415889-24-013504","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20651.0,"shares_display":"20,651","price_per_share":42.31705820541378,"price_display":"42.32","price_state":"stated","total_value":873889.569,"total_display":"873,889.57","total_whole":"873,890","shares_owned_after":51206.0,"shares_owned_after_display":"51,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2278533,"accession":"0001415889-24-013504","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-013504","line_url":"/filing/0001415889-24-013504","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10186.0,"shares_display":"10,186","price_per_share":42.268385038287846,"price_display":"42.27","price_state":"stated","total_value":430545.77,"total_display":"430,545.77","total_whole":"430,546","shares_owned_after":53171.0,"shares_owned_after_display":"53,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2660297,"accession":"0001415889-24-010753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010753","line_url":"/filing/0001415889-24-010753#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5714.0,"shares_display":"5,714","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":228560.0,"total_display":"228,560.00","total_whole":"228,560","shares_owned_after":53171.0,"shares_owned_after_display":"53,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-12","scope":"insider"},{"id":9271907,"accession":"0001209191-23-010595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010595","line_url":"/filing/0001209191-23-010595#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, Finance, Chief Acct Offcr)","role_mark":"O","role_mark_label":"Officer (SVP, Finance, Chief Acct Offcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance, Chief Acct Offcr","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5714.0,"shares_display":"5,714","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":39998.0,"total_display":"39,998.00","total_whole":"39,998","shares_owned_after":22679.0,"shares_owned_after_display":"22,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-17","scope":"insider"},{"id":8722481,"accession":"0001209191-23-007770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007770","line_url":"/filing/0001209191-23-007770#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001861684","owner_name":"Young Joseph R","owner_display_name":"Young Joseph R","owner_url":"/insider/0001861684","role":"Officer (SVP, Finance, Chief Acct Offcr)","role_mark":"O","role_mark_label":"Officer (SVP, Finance, Chief Acct Offcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance, Chief Acct Offcr","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5714.0,"shares_display":"5,714","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":39998.0,"total_display":"39,998.00","total_whole":"39,998","shares_owned_after":22679.0,"shares_owned_after_display":"22,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-06","filed_date":"2023-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Officer (SVP, FINANCE, CHIEF ACCT OFFCR)","n_filings":6,"first_seen":"2023-02-08","last_seen":"2026-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861684","retrieved_at":"2026-08-26T11:58:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}